newsfilter
← Latest News
Business Wire·

ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) ("IPA" or the "Company"), a company operating at the convergence of TechBio and biological intelligence, today announced that it has received formal notification from The